Obesity contributes to reduced life expectancy because of its link with type 2 diabetes and cardiovascular disease. Yet, targeting this poorly diagnosed, ill-defined, and underaddressed modifiable risk factor remains a challenge. In this review, we emphasize that the tendency among health care professionals to amalgam all forms of obesity altogether as a single entity may contribute to such difficulties and discrepancies.

Editors

Editor-in-Chief
Valentin Fuster, MD, PhD, MACC

CME Editor
Ragavendra R. Baliga, MD

Authors
Jean-Pierre Després, CQ, PHD

André C. Carpentier, MD

André Tchernof, PHD

Ian J. Neeland, MD

Paul Poirier, MD, PHD

Important Dates

Date of Release: July 26, 2021
Term of Approval/Date of CME/MOC/ECME Expiration: July 25, 2022